WallStreetZenWallStreetZen

NASDAQ: CRIS
Curis Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CRIS stock forecasts and price targets.

Forecast return on equity

Is CRIS forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is CRIS forecast to generate an efficient return on assets?

Company
-18.61%
Industry
115.15%
CRIS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CRIS earnings per share forecast

What is CRIS's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$1.83
Avg 2 year Forecast
-$1.12
Avg 3 year Forecast
-$0.61

CRIS revenue forecast

What is CRIS's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$12.5M+7.18%
Avg 2 year Forecast
$20.8M+78.94%
Avg 3 year Forecast
$45.7M+292.53%
CRIS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CRIS revenue growth forecast

How is CRIS forecast to perform vs Biotechnology companies and vs the US market?

Company
53.89%
Industry
118.19%
Market
23.42%
CRIS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CRIS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CRIS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CRIS$1.06N/AN/A
PHIO$1.29$14.00+985.27%Buy
CLRB$3.31N/AN/A
ALLR$0.90$9.50+955.56%Buy
COCP$0.96N/AN/A
View Top Biotech Stocks

Curis Stock Forecast FAQ

What is CRIS's earnings growth forecast for 2026-2028?

(NASDAQ: CRIS) Curis's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 68.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.82%.

Curis's earnings in 2026 is -$36,556,000.On average, 7 Wall Street analysts forecast CRIS's earnings for 2026 to be -$23,658,508, with the lowest CRIS earnings forecast at -$32,182,501, and the highest CRIS earnings forecast at -$17,919,390. On average, 6 Wall Street analysts forecast CRIS's earnings for 2027 to be -$14,472,558, with the lowest CRIS earnings forecast at -$17,611,684, and the highest CRIS earnings forecast at -$10,724,484.

In 2028, CRIS is forecast to generate -$7,912,458 in earnings, with the lowest earnings forecast at -$8,615,788 and the highest earnings forecast at -$7,059,154.

If you're new to stock investing, here's how to buy Curis stock.

What is CRIS's revenue growth forecast for 2026-2028?

(NASDAQ: CRIS) Curis's forecast annual revenue growth rate of 53.89% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 118.19%, and while it is forecast to beat the US market's average forecast revenue growth rate of 23.42%.

Curis's revenue in 2026 is $11,650,000.On average, 7 Wall Street analysts forecast CRIS's revenue for 2026 to be $161,442,587, with the lowest CRIS revenue forecast at $145,708,173, and the highest CRIS revenue forecast at $180,551,432. On average, 6 Wall Street analysts forecast CRIS's revenue for 2027 to be $269,514,870, with the lowest CRIS revenue forecast at $148,242,228, and the highest CRIS revenue forecast at $556,587,122.

In 2028, CRIS is forecast to generate $591,236,448 in revenue, with the lowest revenue forecast at $285,081,209 and the highest revenue forecast at $1,099,598,948.

What is CRIS's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CRIS) forecast ROA is -18.61%, which is lower than the forecast US Biotechnology industry average of 115.15%.

What is CRIS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CRIS) Curis's current Earnings Per Share (EPS) is -$3.53. On average, analysts forecast that CRIS's EPS will be -$1.83 for 2026, with the lowest EPS forecast at -$2.49, and the highest EPS forecast at -$1.39. On average, analysts forecast that CRIS's EPS will be -$1.12 for 2027, with the lowest EPS forecast at -$1.36, and the highest EPS forecast at -$0.83. In 2028, CRIS's EPS is forecast to hit -$0.61 (min: -$0.67, max: -$0.55).

What is CRIS's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CRIS) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.